FI944428A0 - Antiviral peptides - Google Patents

Antiviral peptides

Info

Publication number
FI944428A0
FI944428A0 FI944428A FI944428A FI944428A0 FI 944428 A0 FI944428 A0 FI 944428A0 FI 944428 A FI944428 A FI 944428A FI 944428 A FI944428 A FI 944428A FI 944428 A0 FI944428 A0 FI 944428A0
Authority
FI
Finland
Prior art keywords
antiviral peptides
antiviral
peptides
Prior art date
Application number
FI944428A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI944428A (en
Inventor
Colin William Greengrass
Stephen Derek Albert Street
Peter John Whittle
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206462A external-priority patent/GB9206462D0/en
Priority claimed from GB939301638A external-priority patent/GB9301638D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of FI944428A publication Critical patent/FI944428A/en
Publication of FI944428A0 publication Critical patent/FI944428A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI944428A 1992-03-25 1994-09-23 Antiviral peptides FI944428A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929206462A GB9206462D0 (en) 1992-03-25 1992-03-25 Antiviral peptides
GB939301638A GB9301638D0 (en) 1993-01-27 1993-01-27 Antiviral peptides
PCT/EP1993/000597 WO1993019059A1 (en) 1992-03-25 1993-03-13 Antiviral peptides

Publications (2)

Publication Number Publication Date
FI944428A FI944428A (en) 1994-09-23
FI944428A0 true FI944428A0 (en) 1994-09-23

Family

ID=26300586

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944428A FI944428A0 (en) 1992-03-25 1994-09-23 Antiviral peptides

Country Status (13)

Country Link
EP (1) EP0632808A1 (en)
JP (1) JPH07501556A (en)
KR (1) KR950700901A (en)
AU (1) AU3748393A (en)
BR (1) BR9306138A (en)
CA (1) CA2131154A1 (en)
CZ (1) CZ229594A3 (en)
FI (1) FI944428A0 (en)
HU (1) HU9402744D0 (en)
NO (1) NO943540L (en)
RU (1) RU94041225A (en)
SK (1) SK114094A3 (en)
WO (1) WO1993019059A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094344T3 (en) * 1991-01-02 1997-01-16 Merrell Pharma Inc ANTI-VIRAL COMPOUNDS.
CA2166693C (en) * 1993-07-08 1999-08-24 Daniel Schirlin Difluoro statone analogs
CN1130898A (en) * 1993-09-09 1996-09-11 默里尔药物公司 Difluoro statone antiviral analogs
US6114380A (en) * 1995-12-18 2000-09-05 Merrell Pharmaceuticals Inc. Difluoro statone analogs
GB9601680D0 (en) 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
PT1058683E (en) * 1998-02-02 2003-04-30 Lg Chemical Ltd FARNESIL-TRANSFERASE INHIBITORS WITH A PIPERIDINE STRUCTURE AND PREPARATION PROCESS
US6809200B2 (en) 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
BRPI0608178A2 (en) 2005-04-14 2009-11-17 Hoffmann La Roche aminopyrazole derivatives, their manufacture, pharmaceutical composition and use as pharmaceutical agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91780A (en) * 1988-10-04 1995-08-31 Abbott Lab Renin inhibiting hexanoic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
CA2010531A1 (en) * 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
AU5407190A (en) * 1989-04-18 1990-11-16 Upjohn Company, The Peptides having novel polar n-terminal groups
DE4001236A1 (en) * 1990-01-18 1991-07-25 Bayer Ag New oligopeptide(s) contg. 2-amino-2-methyl propionic acid residue - are antiviral agents for human or veterinary therapy including treatment of AIDS and ARC

Also Published As

Publication number Publication date
WO1993019059A1 (en) 1993-09-30
KR950700901A (en) 1995-02-20
EP0632808A1 (en) 1995-01-11
FI944428A (en) 1994-09-23
HU9402744D0 (en) 1994-12-28
JPH07501556A (en) 1995-02-16
RU94041225A (en) 1996-07-20
CA2131154A1 (en) 1993-09-30
CZ229594A3 (en) 1995-04-12
NO943540D0 (en) 1994-09-23
SK114094A3 (en) 1995-04-12
NO943540L (en) 1994-11-21
BR9306138A (en) 1998-06-23
AU3748393A (en) 1993-10-21

Similar Documents

Publication Publication Date Title
NO942066D0 (en) peptide
DE69315842D1 (en) PEPTIDE COMPOUNDS
DE69325333D1 (en) Antiviral composition
NO308752B1 (en) Produksjonsnippel
ITMI931471A1 (en) SCI
ATA255692A (en) SPORTSHOE
FI940109A (en) peptides
FI953127A0 (en) purine
BR9306138A (en) Antiviral Peptides
GB9210744D0 (en) Antiviral peptides
NO932237L (en) Linear peptides
LV10286A (en) Peptide Compounds
ATA227792A (en) SPORTSHOE
LV10287A (en) Peptide Compounds
ZA932079B (en) Antiviral peptides
KR940018006U (en) Jeonju Complete
KR940000399U (en) Ossuary complex
ITMI922963A0 (en) CYCLIC PEPTIDES
ITFE920014V0 (en) ENDOLANCET B
BR7200879U (en) COCHO SALEIRO BIAZI
BR7201352U (en) LUNIN
ATA27393A (en) ALPINSKI
ATA58493A (en) LOCHSTEIN
BR7200188U (en) HYDRO-ASHTRAY
BR7200229U (en) DOCA-DOUBLE